An evaluation of the clinical and cost-effectiveness of pulmonary artery flotation catheters (PAC-Man) in intensive care.

Completed

• Conditions: Heart disease; Circulatory System

• Registration Number: ISRCTN04539889
• Lead Sponsor: Department of Health (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2003-04-25
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 1041

Inclusion Criteria

All intensive care admissions, including high risk surgical patients.

Exclusion Criteria

Not provided at time of registration.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hospital mortality, defined as death before discharge from hospital, incorporating death before discharge from ICU. There are no secondary outcome measures unless otherwise indicated by results of the systematic review. <br>Economic Evaluation: The costs of care will be estimated using a top-down method. Cost-effectiveness ratios will be estimated for each outcome. Appropriate incremental cost-effectiveness ratios will also be calculated and sensitivity analysis around the cost and outcome of care will be undertaken.

Secondary Outcome Measures

Name	Time	Method
ot provided at time of registration.